Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Timolol maleate gel for proliferative superficial infantile hemangioma (Phase III, China)
CTR20260985Phase 3Active
- Sponsor
- Shanghai Aoxuan Biopharmaceutical Technology
- Start
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of timolol in Capillary Haemangioma, sponsored by Shanghai Aoxuan Biopharmaceutical Technology. Started Mar 2026; status: active.
02
Drugs
timolol
03
Conditions
Capillary Haemangioma
Beyond the preview
Go deeper on CTR20260985.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20260985.